Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire

Showing 15 posts of 170 posts found.

shire_image_4

Shire announces split into two business units, downgrades revenue forecast

January 9, 2018
Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease

Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …

News
busch

Pharma carousel sees Bayer discovery chief head to Shire

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

Appointment
shire_image_4

Shire to streamline operations with 100-strong plant sale and in-house Cinryze production

October 31, 2017
Manufacturing and Production, Sales and Marketing Cinryze, Shire, pharma

Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, having already entered active …

News
shire_image

Shire takes fight to Allergan over dry-eye drug

October 4, 2017
Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …

News
shire_image

Shire submits dry-eye drug for marketing approval

August 15, 2017
Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …

News
shire_austria_facility

Shire shifts vaccine facility from Baxalta deal to MSD

August 8, 2017
Manufacturing and Production Baxalta, MSD, Shire, biotech, drugs, pharma, pharmaceutical

As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …

News
shire_image

Shire and Roche haemophilia spat spills into court

July 10, 2017
Sales and Marketing Roche, Shire, haemophilia

Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …

News
shire_image

10 years later, Shire gains FDA approval for ADHD drug

June 21, 2017
Research and Development, Sales and Marketing ADHD, Shire

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

News
shire_image

Shire creates 150 jobs with Dublin HQ relocation

May 2, 2017
Manufacturing and Production Dublin, Shire

Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased …

News
blood-1813410_960_720

‘World Hemophilia Day’ marked by release of data

April 20, 2017
Medical Communications, Research and Development Roche, Shire, haemophilia

‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies …

News
shire_image_4

NICE turns down Shire’s pancreatic cancer treatment

April 4, 2017
Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire

NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …

News
shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017
Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …

News
roche_close

Death in trial of Roche’s potential blockbuster haemophilia drug

February 24, 2017
Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia

Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …

News
the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017
Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026